Fny Investment Advisers, LLC Immunity Bio, Inc. Call Options Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 19, 2022	BUY	$3.65 - $6.43 $3 - $6	1 Added 0.56%	180 $0
Q2 2022 Jul 12, 2022	SELL	$2.68 - $6.14 $402 - $921	-150 Reduced 45.59%	179 $0
Q4 2021 Jan 10, 2022	BUY	$5.67 - $10.18 $1,014 - $1,822	179 Added 119.33%	329 $2,000
Q3 2021 Oct 13, 2021	BUY	$9.17 - $14.24 $458 - $712	50 Added 50.0%	150 $1,000
Q2 2021 Jul 14, 2021	BUY	$13.41 - $22.4 $442 - $739	33 Added 49.25%	100 $1,000
Q1 2021 Apr 12, 2021	BUY	$12.83 - $42.25 $859 - $2,830	67 New	67 $1,000

213

71.2M

1.64M

1.45M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.3B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.